Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy

Surgery (United States)

Volumn 151, Issue 6, 2012, Pages 844-850

  Lang, Brian Hung Hin ^a   Wong, Irene Oi Ling ^b   Wong, Kai Pun ^a   Cowling, Benjamin J ^b   Wan, Koon Yat ^b  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVOR; CHILD; COLON CANCER; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; NONSYNCHRONOUS SECOND PRIMARY MALIGNANCY; POPULATION; PRIORITY JOURNAL; RECTUM CANCER; RISK FACTOR; SCHOOL CHILD; SECOND CANCER; SEX DIFFERENCE; STANDARDIZED INCIDENCE RATIO; STOMACH CANCER; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; TUMOR VOLUME; UTERINE CERVIX CANCER; UTERUS CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; IODINE RADIOISOTOPES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84861594243     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2011.12.019     Document Type: Article

References (23)

1. Cancer incidence and mortality in Hong Kong 1983-2006. Hong Kong Cancer Registry, Hong Kong. Available from: http://www3.ha.org.hk/cancereg/e-stat.asp.
2. B.H. Lang, C.Y. Lo, W.F. Chan, K.Y. Lam, and K.Y. Wan Prognostic factors in papillary and follicular thyroid carcinoma: implications for cancer staging Ann Surg Oncol 14 2007 730 738
3. I.D. Hay, T. Gonzalez-Losada, M.S. Reinalda, J.A. Honetschlager, M.L. Richards, and G.B. Thompson Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008 World J Surg 34 2010 1192 1202
4. B.H. Lang, C.Y. Lo, I.O. Wong, and B.J. Cowling Impact of second primary malignancy on outcomes of differentiated thyroid carcinoma Surgery 148 2010 1191 1196
5. C. Rubino, F. de Vathaire, M.E. Dottorini, P. Hall, C. Schvartz, and J.E. Couette Second primary malignancies in thyroid cancer patients Br J Cancer 89 2003 1638 1644
6. A.P. Brown, J. Chen, Y.J. Hitchcock, A. Szabo, D.C. Shrieve, and J.D. Tward The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer J Clin Endocrinol Metab 93 2008 504 515
7. T.C. Sandeep, M.W. Strachan, R.M. Reynolds, D.H. Brewster, G. Scelo, and E. Pukkala Second primary cancers in thyroid cancer patients: a multinational record linkage study J Clin Endocrinol Metab 91 2006 1819 1825
8. E. Berthe, M. Henry-Amar, and J.J. Michels Risk of second primary cancer following differentiated thyroid cancer Eur J Nucl Med Mol Imaging 31 2004 685 691
9. A.M. Sawka, L. Thabane, and L. Parlea Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis Thyroid 19 2009 451 457
10. R.B. Verkooijen, J.W. Smit, J.A. Romijn, and M.P. Stokkel The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer Eur J Endocrinol 155 2006 801 806
11. A.J. Canchola, P.L. Horn-Ross, and D.M. Purdie Risk of second primary malignancies in women with papillary thyroid cancer Am J Epidemiol 15 2006 521 527
12. B.H. Lang, C.Y. Lo, W.F. Chan, K.Y. Lam, and K.Y. Wan Staging systems for papillary thyroid carcinoma: a review and comparison Ann Surg 245 2007 266 278
13. I.O. Wong, W.S. Chan, S. Choi, S.V. Lo, and G.M. Leung Moral hazard or realised access to care? Empirical observation in Hong Kong Health Policy 75 2006 251 261
14. S. Subramanian, D.P. Goldstein, and L. Parlea Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis Thyroid 17 2007 1277 1288
15. C.M. Ronckers, P. McCarron, and E. Ron Thyroid cancer and multiple primary tumors in the SEER cancer registries Int J Cancer 117 2005 281 288
16. B.H. Lang, and K.P. Wong Risk factors for nonsynchronous second primary malignancy and related death in patients with differentiated thyroid carcinoma Ann Surg Oncol 18 2011 3559 3565
17. S.C. Chuang, M. Hashibe, and G.P. Yu Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers Cancer Lett 238 2006 42 52
18. D.S. Cooper, G.M. Doherty, B.R. Hauger, R.T. Kloos, S.L. Lee, and S.J. Mandel Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 2009 1167 1214
19. T. Kogai, K. Taki, and G.A. Brent Enhancement of sodium/iodide symporter expression in thyroid and breast cancer Endocr Relat Cancer 13 2006 797 826
20. N. Bhattacharyya, and W. Chien Risk of second primary malignancy after radioactive iodine treatment for differentiated thyroid carcinoma Ann Otol Rhinol Laryngol 115 2006 607 610
21. Presentation by Shane Solomon, the Chief Executive of Hospital Authority. Available from http://www.ha.org.hk/upload/presentation/47.pdf.
22. C. Cybulski, B. Górski, and T. Huzarski CHEK2 is a multiorgan cancer susceptibility gene Am J Hum Genet 75 2004 1131 1135
23. E.K. Wei, K.Y. Wolin, and G.A. Colditz Time course of risk factors in cancer etiology and progression J Clin Oncol 28 2010 4052 4057